Oculis Holding AG (OCS) Non-Current Assets (2021 - 2026)

Oculis Holding AG's (OCS) quarterly Non-Current Assets came in at $21.7 million in Q1 2026, up 26.56% year-on-year from $17.1 million in Q1 2025, and up 1.36% quarter-over-quarter from $21.4 million in Q4 2025.

Oculis Holding AG (OCS) Non-Current Assets (2021 - 2026) Analysis & Trends

Oculis Holding AG's Non-Current Assets history runs 6 years deep, the most recent figure standing at $21.7 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 26.56% year-over-year to $21.7 million in Q1 2026; TTM through Mar 2026 was $21.7 million, a 26.56% increase from a year earlier, with the FY2025 full-year figure at $20.6 million, up 17.22% from the prior year.
  • Non-Current Assets rose to $21.7 million in Q1 2026 per OCS's latest filing, from $21.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $21.7 million in Q1 2026 and bottomed at $13.9 million in Q4 2022.
  • The 5-year median for Non-Current Assets is $16.3 million (2024), against an average of $17.2 million.
  • Across the five-year window, Non-Current Assets gained 4.02% in 2024 and rose 29.88% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $13.9 million in 2022, then grew by 8.08% to $15.0 million in 2023, then grew by 17.34% to $17.6 million in 2024, then advanced by 21.08% to $21.4 million in 2025, then climbed by 1.36% to $21.7 million in 2026.
  • Per Business Quant, the three latest OCS Non-Current Assets figures stand at $21.7 million (Q1 2026), $21.4 million (Q4 2025), and $21.2 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn 910.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 21.65 Mn
Dec 31, 2025 21.36 Mn
Sep 30, 2025 21.16 Mn
Jun 30, 2025 18.63 Mn
Mar 31, 2025 17.11 Mn
Dec 31, 2024 17.64 Mn
Sep 30, 2024 16.29 Mn
Jun 30, 2024 15.59 Mn
Mar 31, 2024 15.20 Mn
Dec 31, 2023 15.04 Mn
Sep 30, 2023 15.22 Mn
Jun 30, 2023 14.99 Mn
Dec 31, 2022 13.91 Mn
Dec 31, 2021 10.91 Mn